Jackson Hammond of the American Action Forum said financial pressure was a driver of PhRMA's increased lobbying efforts.
340B Lobbying Reaches Record Levels in 2023
Lobbying on 340B issues reached a record level in 2023, according to annual tallies of congressional lobbying disclosures. That flurry [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.